BioMarin Pharmaceuticals Inc(BMRN)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$55.59
52-Week Range
$49.26 – $66.28
YTD
-6.49%
IV Rank (30D)
52.27
Straddle Price
$4.03
P/C Vol Ratio
0.19
Market Cap
$10.6B
Fair Value
+2.4% vs price
Confidence: 56% Alpha Score: 0.03

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.49%
Beta vs SPY1.00
Cost of Equity (CAPM)9.99% (VRP-adj)
WACC9.01%
Volatility Risk Premium+19.6pp (IV − HV30), ERP adj +50bps
Effective Tax Rate30.3%
Rev. Growth (YoY, DCF input)-7.2%
DCF Horizon12 years explicit + fade
Free Cash Flow (TTM)$0.8B
Return on Equity (TTM)4.3%
Book / Price57.9% — banking bias active (P/B is primary)
Gross Margin (TTM)76.5%
FCF Margin (TTM)23.7%
Debt / Equity0.23
Quality Score4/6 — high quality (12y DCF)
Market-Implied Growth-0.6% (reverse-DCF on current price)
SMA 50$54.26 (Market Anchor value)
SMA 20 / Bollinger Mid$55.12
Bollinger Width / SMA2019.8% (drives anchor stability)
Net Debt$-0.8B
Market Cap$11B
Peers used for multiples: BIIB, REGN, TECH, VCYT (filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$56.91
Current Price
$55.59
Deviation
+2.4%
Forward-Return Rank LONG gated
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -5.3% -0.97 -0.64 3.6%
42d -5.8% -0.17 -0.24 11.0%
63d -6.8% -0.31 -0.31 6.8%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF $37.31 30%
DDM (Gordon) n/a 0%
Peer P/E $47.79 7% median 34.9× · 4 peers
Peer EV/EBITDA $52.59 9% median 24.5× · 4 peers
Peer P/B $82.54 12% median 2.6× · 4 peers
Peer P/S $97.41 12% median 5.9× · 4 peers
Market Anchor (SMA50) $54.26 31% stability 51% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-22 · updated 2026-06-22 19:19:32.849000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$10.6B

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +1.03% 23
Feb -1.02% 23
Mar -0.57% 23
Apr +0.51% 23
May +1.10% 23
Jun +2.19% 23
Jul +4.68% 22
Aug +0.10% 22
Sep -3.24% 23
Oct -2.83% 23
Nov +6.85% 23
Dec +5.10% 23
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $55.19
SMA 50: $54.24
SMA 200: $55.65
Current: $55.59
EMA 12: $55.35
EMA 26: $54.95
MACD: 0.4005 | Signal: -0.0751
BULLISH
ADX (14): 20.34
WEAK TREND
+DI: 24.47
−DI: 18.16
Momentum Oscillators
RSI (14): 52.74
NEUTRAL
Stoch %K: 39.78
Stoch %D: 42.37
Williams %R: -50.95
Volume & Volatility
BB Upper: $58.17
BB Lower: $52.21
NEUTRAL
OBV: 12,239,869
Vol SMA 20: 2,251,980
Vol ROC: -42.40%
ATR: $1.63
True Range: $1.19
HV 20: 42.9%
HV 30: 44.8%
HV 60: 37.2%

Data Summary
Data Points: 500
Last Updated: 2026-06-22T19:20:24.904000
Date Range: 2024-06-21T00:00:00 – 2026-06-18T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
8 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-05 After-Close 7.96% 5.17% 0.65x Within
2024-10-29 After-Close 7.72% 4.20% 0.54x Within
2025-02-19 After-Close 8.10% 3.17% 0.39x Within
2025-05-01 After-Close 7.45% 1.15% 0.15x Within
2025-08-04 After-Close 10.09% 3.49% 0.35x Within
2025-10-27 After-Close 11.53% 0.94% 0.08x Within
2026-01-12 After-Close 4.99% 4.87% 0.98x Within
2026-05-04 After-Close 10.14% 3.71% 0.37x Within
Options Activity
IV Rank (30D)
52.27
IV Rank (7D)
52.27
Avg IV
69.3%
Straddle (30D)
$4.03
Straddle (7D)
$4.03
P/C Volume
0.19
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.48
Correlation (SPY)
17.3%
0.03
Ann. Volatility
34.8%
SPY Volatility
12.4%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 196,047,000 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

576 filers777,081,659 shares$10.86B value396.38% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 70,306,301 $1.17B 10.75% 35.86% 2026-03-31
2 VANGUARD GROUP INC Custodian 18,127,847 $1.08B 9.92% 9.25% 2025-12-31
3 DODGE & COX 14,561,759 $822.59M 7.57% 7.43% 2026-03-31
4 PRIMECAP MANAGEMENT CO/CA/ 14,194,005 $801.82M 7.38% 7.24% 2026-03-31
5 AQR CAPITAL MANAGEMENT LLC Custodian 7,676,541 $429.35M 3.95% 3.92% 2026-03-31
6 STATE STREET CORP 18,861,079 $423.28M 3.90% 9.62% 2026-03-31
7 VIKING GLOBAL INVESTORS LP 7,062,077 $398.94M 3.67% 3.60% 2026-03-31
8 CITADEL ADVISORS LLC Custodian 4,512,634 $254.92M 2.35% 2.30% 2026-03-31
9 GEODE CAPITAL MANAGEMENT, LLC Custodian 3,819,441 $215.81M 1.99% 1.95% 2026-03-31
10 DIMENSIONAL FUND ADVISORS LP Custodian 3,802,930 $214.80M 1.98% 1.94% 2026-03-31
11 Vestal Point Capital, LP 3,575,000 $201.95M 1.86% 1.82% 2026-03-31
12 FMR LLC Custodian 3,567,031 $201.50M 1.86% 1.82% 2026-03-31
13 Capital Research Global Investors 3,491,386 $197.23M 1.82% 1.78% 2026-03-31
14 MILLENNIUM MANAGEMENT LLC Custodian 10,510,308 $177.29M 1.63% 5.36% 2026-03-31
15 MORGAN STANLEY Custodian 3,387,620 $138.64M 1.28% 1.73% 2025-12-31
16 Assenagon Asset Management S.A. 1,920,658 $108.50M 1.00% 0.98% 2026-03-31
17 TENOR CAPITAL MANAGEMENT Co., L.P. 111,500,000 $108.12M 1.00% 56.87% 2026-03-31
18 FIRST TRUST ADVISORS LP 1,672,491 $94.48M 0.87% 0.85% 2026-03-31
19 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,587,683 $89.69M 0.83% 0.81% 2026-03-31
20 NORTHERN TRUST CORP Custodian 1,586,384 $89.61M 0.82% 0.81% 2026-03-31
21 UBS Group AG Custodian 1,562,852 $84.62M 0.78% 0.80% 2026-03-31
22 BALYASNY ASSET MANAGEMENT L.P. 1,362,752 $76.98M 0.71% 0.70% 2026-03-31
23 Jones Hill Capital LP 1,268,390 $71.65M 0.66% 0.65% 2026-03-31
24 DnB Asset Management AS 1,221,387 $69.00M 0.64% 0.62% 2026-03-31
25 Point72 Asset Management, L.P. 1,199,206 $67.74M 0.62% 0.61% 2026-03-31
20 filers$100.41M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $41.77M 41.60% 2026-03-31
2 UBS Group AG Custodian $7.95M 7.92% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $7.28M 7.25% 2026-03-31
4 JANE STREET GROUP, LLC Custodian $6.88M 6.85% 2026-03-31
5 Point72 Asset Management, L.P. $5.65M 5.63% 2026-03-31
6 WOLVERINE TRADING, LLC Custodian $4.37M 4.35% 2025-09-30
7 GROUP ONE TRADING LLC Custodian $4.01M 3.99% 2026-03-31
8 Walleye Trading LLC $3.45M 3.44% 2026-03-31
9 MILLENNIUM MANAGEMENT LLC Custodian $3.28M 3.26% 2026-03-31
10 SIMPLEX TRADING, LLC Custodian $3.22M 3.21% 2026-03-31
11 IMC-Chicago, LLC Custodian $2.99M 2.98% 2026-03-31
12 Greenland Capital Management LP $1.98M 1.97% 2026-03-31
13 Walleye Capital LLC $1.87M 1.86% 2026-03-31
14 CITIGROUP INC Custodian $1.69M 1.69% 2026-03-31
15 JPMORGAN CHASE & CO Custodian $1.64M 1.64% 2026-03-31
16 Twin Tree Management, LP $1.19M 1.19% 2026-03-31
17 CAPITAL FUND MANAGEMENT S.A. $796.51K 0.79% 2026-03-31
18 TUDOR INVESTMENT CORP ET AL $305.05K 0.30% 2026-03-31
19 INSPIRION WEALTH ADVISORS, LLC $56.49K 0.06% 2026-03-31
20 Raiffeisen Bank International AG $39.32K 0.04% 2026-03-31
15 filers$68.01M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $23.45M 34.48% 2026-03-31
2 UBS Group AG Custodian $16.13M 23.71% 2026-03-31
3 Caption Management, LLC $11.83M 17.40% 2026-03-31
4 CITADEL ADVISORS LLC Custodian $3.19M 4.68% 2026-03-31
5 Walleye Trading LLC $2.23M 3.28% 2026-03-31
6 IMC-Chicago, LLC Custodian $1.74M 2.56% 2026-03-31
7 CITIGROUP INC Custodian $1.69M 2.49% 2026-03-31
8 NOMURA HOLDINGS INC $1.69M 2.49% 2026-03-31
9 JPMORGAN CHASE & CO Custodian $1.64M 2.42% 2026-03-31
10 WOLVERINE TRADING, LLC Custodian $1.46M 2.15% 2025-09-30
11 JANE STREET GROUP, LLC Custodian $971.63K 1.43% 2026-03-31
12 GROUP ONE TRADING LLC Custodian $621.39K 0.91% 2026-03-31
13 TUDOR INVESTMENT CORP ET AL $531.01K 0.78% 2026-03-31
14 SIMPLEX TRADING, LLC Custodian $468.87K 0.69% 2026-03-31
15 Walleye Capital LLC $350.24K 0.51% 2026-03-31
Insider Activity
Latest: 2026-06-04
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-04 ELIZABETH M ANDERSON Director Award (A) +7,490 EDGAR
2026-06-04 Barbara W. Bodem Director Award (A) +7,490 EDGAR
2026-06-04 IAN T CLARK Director Award (A) +7,490 EDGAR
2026-06-04 Willard H Dere Director Award (A) +7,490 EDGAR
2026-06-04 Mark J Enyedy Director Award (A) +7,490 EDGAR
2026-06-04 ROBERT J. HOMBACH Director Award (A) +7,490 EDGAR
2026-06-04 Maykin Ho Director Award (A) +7,490 EDGAR
2026-06-04 Timothy P Walbert Director Award (A) +7,490 EDGAR
2026-06-04 Athena Countouriotis Director Award (A) +7,490 EDGAR
2026-05-21 Cristin Hubbard EVP, Chief Commercial Officer Tax (F) −2,318 $50.20 -$116.4K EDGAR
2026-05-11 Gregory R Friberg EVP, Chief R&D Officer Sell (S) −3,281 $53.85 -$176.7K EDGAR
2026-03-19 Alexander Hardy Chief Executive Officer Tax (F) −4,252 $56.05 -$238.3K EDGAR
2026-03-19 Brian Mueller EVP, Chief Financial Officer Tax (F) −2,117 $56.05 -$118.7K EDGAR
2026-03-19 Charles Greg Guyer EVP, Chief Technical Officer Tax (F) −1,693 $56.05 -$94.9K EDGAR
2026-03-19 George Eric Davis EVP, Chief Legal Officer Tax (F) −1,273 $56.05 -$71.4K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
41 insiders · @ $55.59
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 JEAN JACQUES BIENAIME Director 473,892 $26.34M -$241.37M 336 2024-05-21
2 Alexander Hardy Chief Executive Officer 214,635 $11.93M $0 7 2026-03-19
3 ROBERT BAFFI President, Global Mfg/Tech Ops 189,020 $10.51M -$40.09M 90 2020-03-24
4 HENRY J FUCHS President, Worldwide R&D 185,074 $10.29M -$62.29M 112 2024-09-17
5 STEVE ASELAGE EVP, Chief Business Officer 154,375 $8.58M -$13.49M 33 2012-07-05
6 RICHARD A MEIER Director 127,426 $7.08M -$2.72M 39 2025-05-22
7 Brian Mueller EVP, Chief Financial Officer 123,314 $6.85M -$13.92M 82 2026-03-19
8 ELAINE J HERON Director 97,720 $5.43M -$8.48M 34 2024-06-04
9 Charles Greg Guyer EVP, Chief Technical Officer 84,140 $4.68M -$2.95M 22 2026-03-19
10 George Eric Davis EVP, Chief Legal Officer 78,560 $4.37M -$54.02M 139 2026-03-19
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-05-07
Last 30d: 0 filings  ·  Last 90d: 1 filing · $177K notice value · 1 unique filer

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.

Top 90-day filers: Friberg Gregory R (1, $177K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-05-07 Friberg Gregory R Officer 3,281 $176.7K 2026-05-07 Fidelity Brokerage Services LLC EDGAR
2026-03-11 Guyer Charles Greg Officer 16,486 $996.7K 2026-03-11 Fidelity Brokerage Services LLC EDGAR
2026-02-26 Friberg Gregory R Officer 6,326 $381.9K 2026-02-26 Fidelity Brokerage Services LLC EDGAR
2026-02-26 Davis George Eric Officer 26,061 $1.60M 2026-02-26 Fidelity Brokerage Services LLC EDGAR
2025-05-20 Burkhart Erin Officer 1,786 $105.9K 2025-05-20 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2025-05-02 Hubbard Cristin Officer 273 $17.7K 2025-05-02 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2025-03-19 Burkhart Erin Officer 1,295 $92.6K 2025-03-19 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2025-03-06 Guyer Charles Greg Officer 7,034 $501.4K 2025-03-06 Fidelity Brokerage Services LLC EDGAR
2025-02-24 Burkhart Erin Officer 1,344 $91.9K 2025-02-24 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2024-11-12 Guyer Charles Greg Officer 5,278 $350.3K 2024-11-12 Fidelity Brokerage Services LLC EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
Recent SEC Filings
Latest: 2026-06-04
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-06-04 0001628280-26-040812 EDGAR
2026-05-04 0001048477-26-000006 EDGAR
2026-04-27 0001193125-26-179243 EDGAR
2026-04-23 0001193125-26-173770 EDGAR
2026-03-16 0001193125-26-107314 EDGAR
2026-02-23 0001048477-26-000002 EDGAR
2026-02-12 0001193125-26-048736 EDGAR
2026-01-29 0001193125-26-029401 EDGAR
2026-01-26 0001193125-26-021718 EDGAR
2026-01-12 0001193125-26-010508 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-26 0001048477-26-000004 EDGAR
2025-02-24 0001048477-25-000007 EDGAR
2024-02-26 0001048477-24-000016 EDGAR
2023-02-27 0001048477-23-000009 EDGAR
2022-02-25 0001048477-22-000012 EDGAR
2021-02-26 0001048477-21-000008 EDGAR
2020-02-27 0001048477-20-000009 EDGAR
2019-02-28 0001564590-19-005033 EDGAR
2018-02-26 0001564590-18-003114 EDGAR
2017-02-27 0001564590-17-002483 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-05 0001048477-26-000008 EDGAR
2025-10-28 0001048477-25-000107 EDGAR
2025-08-05 0001048477-25-000090 EDGAR
2025-05-02 0001048477-25-000051 EDGAR
2024-10-31 0001048477-24-000152 EDGAR
2024-08-05 0001048477-24-000126 EDGAR
2024-04-26 0001048477-24-000070 EDGAR
2023-11-02 0001048477-23-000044 EDGAR
2023-08-02 0001048477-23-000029 EDGAR
2023-04-28 0001048477-23-000020 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/E Ratio40.6
P/B Ratio1.7
P/S Ratio3.3
EV/EBITDA25.1
TTM Revenue$3.2B
TTM Net Income$0.3B
TTM EPS$1.37
ROE4.3%
Debt/Equity0.23